Stockscreener 앱 받기
65.44
3.06%
1.94
전일 마감가:
$63.50
열려 있는:
$63.46
하루 거래량:
1.41M
Relative Volume:
0.61
시가총액:
$8.00B
수익:
$18.47M
순이익/손실:
$-589.53M
주가수익비율:
-12.44
EPS:
-5.26
순현금흐름:
$-399.80M
1주 성능:
-1.51%
1개월 성능:
+13.26%
6개월 성능:
+109.01%
1년 성능:
+37.28%
1일 변동 폭
$63.02
$66.76
1주일 범위
$62.86
$67.98
52주 변동 폭
$29.31
$67.98
Cytokinetics Inc Stock (CYTK) Company Profile
명칭
Cytokinetics Inc
전화
(650) 624-3000
주소
350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
CYTK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYTK
Cytokinetics Inc
|
65.44 | 7.76B | 18.47M | -589.53M | -399.80M | -5.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cytokinetics Inc Stock (CYTK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | Raymond James | Mkt Perform |
| 2025-04-24 | 개시 | Barclays | Overweight |
| 2025-02-07 | 개시 | Citigroup | Buy |
| 2025-01-22 | 개시 | Stifel | Buy |
| 2024-11-08 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-01-24 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-09 | 개시 | Goldman | Buy |
| 2023-11-07 | 개시 | B. Riley Securities | Buy |
| 2023-08-15 | 개시 | SVB Securities | Outperform |
| 2023-02-17 | 개시 | BofA Securities | Neutral |
| 2022-12-23 | 재확인 | Needham | Buy |
| 2022-12-20 | 개시 | Truist | Buy |
| 2022-10-11 | 개시 | UBS | Buy |
| 2022-01-28 | 개시 | Goldman | Buy |
| 2021-12-22 | 개시 | Oppenheimer | Outperform |
| 2021-12-10 | 개시 | JP Morgan | Overweight |
| 2021-10-07 | 개시 | Jefferies | Buy |
| 2021-03-12 | 개시 | Wolfe Research | Outperform |
| 2021-02-18 | 개시 | Barclays | Overweight |
| 2021-01-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-29 | 개시 | Goldman | Neutral |
| 2020-07-10 | 개시 | Raymond James | Strong Buy |
| 2020-05-05 | 개시 | Mizuho | Buy |
| 2020-04-09 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-09-10 | 재개 | Morgan Stanley | Equal-Weight |
| 2017-11-22 | 재확인 | Morgan Stanley | Overweight |
| 2017-11-22 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2017-11-21 | 재확인 | H.C. Wainwright | Buy |
| 2017-07-31 | 개시 | Morgan Stanley | Overweight |
| 2017-03-08 | 개시 | Rodman & Renshaw | Buy |
| 2017-02-06 | 업그레이드 | Needham | Buy → Strong Buy |
| 2016-12-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2016-07-28 | 재확인 | Needham | Buy |
| 2015-11-10 | 재확인 | FBR Capital | Outperform |
| 2015-11-09 | 재확인 | ROTH Capital | Buy |
| 2015-07-24 | 재확인 | MLV & Co | Buy |
| 2014-12-31 | 재확인 | ROTH Capital | Buy |
| 2014-11-04 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-04-28 | 재확인 | Needham | Buy |
모두보기
Cytokinetics Inc 주식(CYTK)의 최신 뉴스
Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Ready to Jump After Recent Trade: Cytokinetics Inc (CYTK) - Setenews
Rep. Gilbert Ray Cisneros, Jr. Buys Cytokinetics, Incorporated (NASDAQ:CYTK) Stock - Defense World
How Cytokinetics Incorporated (KK3A) stock trades under stagflationWeekly Gains Report & Safe Capital Growth Trade Ideas - newser.com
What macro factors could drive Cytokinetics Incorporated (KK3A) stock higherJuly 2025 Action & Weekly Watchlist for Hot Stocks - newser.com
Insider Sell: B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Is Cytokinetics Incorporated (KK3A) stock trading at attractive multiplesJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
[Form 4] CYTOKINETICS INC Insider Trading Activity - Stock Titan
Cytokinetics Director Sells 5,000 Shares - TradingView
Dir Parshall Sells 5,000 ($323.7K) Of Cytokinetics Inc [CYTK] - TradingView
What market sentiment indicators show for Cytokinetics Incorporated (KK3A) stock2025 Institutional Moves & High Yield Stock Recommendations - newser.com
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea ... - Bluefield Daily Telegraph
Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire
Will Cytokinetics Incorporated (KK3A) stock draw ESG focused funds - newser.com
Cytokinetics Inc (KK3A.HM) Stock Historical Prices & Data - Yahoo! Finance Canada
Cytokinetics Inc (KK3A.HM) Latest Stock News & Headlines - Yahoo! Finance Canada
Cytokinetics Inc (KK3A.HM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Insider Sell Alert: Fady Malik Sells 2,200 Shares of Cytokinetics Inc (CYTK) - GuruFocus
Cytokinetics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Cytokinetics Executive Sells Shares - TradingView
Cytokinetics Grants Stock Options and RSUs to New Executive and Employees as Inducements to Employment - Quiver Quantitative
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
What Does the Market Think About Cytokinetics Inc? - Benzinga
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); enCore Energy ... - Bluefield Daily Telegraph
Cytokinetics Incorporated (CYTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Urgently Reminds Investors of - GlobeNewswire
Total debt per share of Cytokinetics, Incorporated – DUS:KK3A - TradingView
Recover Investment Losses: Class Action Initiated Against Cytokinetics, Incorporated (CYTK) - ACCESS Newswire
Cytokinetics at Jefferies London: Aficamten’s Strategic Path Forward - Investing.com India
CYTK FINAL DEADLINE: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit - Business Wire
Cytokinetics at Jefferies London: Aficamten's Strategic Path Forward - Investing.com
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated Investors - GlobeNewswire
Former Exelixis GC Named Legal Chief At Cytokinetics - Law360
Cytokinetics (CYTK) Supports American Heart Association Initiati - GuruFocus
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders - MarketScreener
Cytokinetics supports American Heart Association initiative to improve care for people living with hypertrophic cardiomyopathy - MarketScreener
Cytokinetics Supports American Heart Association Initiative to Enhance Care for Hypertrophic Cardiomyopathy Patients - Quiver Quantitative
Cytokinetics Supports American Heart Association Initiative - GlobeNewswire
Cytokinetics Shares Surge Amid Legal Challenges and Clinical Promise - Ad-hoc-news.de
Imbria Pharmaceuticals, Inc. announced that it has received funding from a group of investors - MarketScreener
Cytokinetics 24 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Cytokinetics, IncorporatedCYTK - Louisiana First News
November 17, 2025 Deadline: Join Class Action Lawsuit Against Cytokinetics, Incorporated (CYTK)Contact Levi & Korsinsky - ACCESS Newswire
Key facts: Cytokinetics stock drops 12.98%; class action lawsuit filed - TradingView
Can Cytokinetics Incorporated (KK3A) stock deliver double digit returnsWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
CTYK DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Cytokinetics, Incorporated Investors to Join the Class Action Lawsuit - ACCESS Newswire
Cytokinetics Incorporated recovery potential after sell offFed Meeting & Daily Market Momentum Tracking - newser.com
Levi & Korsinsky Urges Cytokinetics, Incorporated (CYTK) Shareholders to Act Before Lead Plaintiff Deadline November 17, 2025 - ACCESS Newswire
CYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages - GlobeNewswire
Cytokinetics Inc (CYTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):